• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOVASCULAR LLC HEARTSTRING III PROXIMAL SEAL; CLAMP, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOVASCULAR LLC HEARTSTRING III PROXIMAL SEAL; CLAMP, VASCULAR Back to Search Results
Model Number HS-3045
Medical Device Problem Code Activation Problem (4042)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/13/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Trackwise id (b)(4).The device has not yet been returned to maquet cardiac surgery for evaluation.We are following up with the customer for the return of the device.A supplemental report will be submitted if the device is received.
 
Event or Problem Description
Related to (b)(6) and (b)(6) (same patient).The hospital reported that during a coronary artery bypass procedure, hst iii seal (4.5mm) was loaded, but here the seal was not released inside the aorta, but only went when the insertion aid was withdrawn from the aortotomy.Replacement device was used to complete the procedure.
 
Additional Manufacturer Narrative
Trackwise#: (b)(4).Corrected sections: h1-- corrected from "malfunction" to "serious injury".The device was returned to the factory for evaluation on 07/07/2023.An investigation was conducted on on 07/18/2023.A visual inspection was conducted.Signs of clinical use and no evidence of blood were observed on the device.The delivery device was returned outside the loading device.The blue slide lock was observed to be off and the white plunger was not depressed.The seal and tension spring assembly were not returned for evaluation.Measurements of the delivery device were taken; the inner diameter was measured at 0.194 inches, the outer diameter was measured at 0.22 inches.The length of the delivery tube was measured at 2.52 inches ((b)(4)).The measurement values recorded for the delivery tube were within the tolerance specifications.Based on the returned condition of the device and evaluation results, the reported failure "activation problem" was not confirmed.The lot # 3000261689 history record review was completed.There were no ncmrs, rework, or deviations documented for the reported lot number.Based on the dhr/lhr review results, it was determined that there is no relation between the batch manufacturing process and the reported failure.
 
Event or Problem Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTSTRING III PROXIMAL SEAL
Common Device Name
CLAMP, VASCULAR
Manufacturer (Section D)
MAQUET CARDIOVASCULAR LLC
45 barbour pond drive
wayne NJ
Manufacturer (Section G)
MAQUET CARDIOVASCULAR LLC
45 barbour pond drive
wayne NJ
Manufacturer Contact
arelean guzman
45 barbour pond drive
wayne, NJ 
MDR Report Key17292930
Report Number2242352-2023-00564
Device Sequence Number17666233
Product Code DXC
UDI-Device Identifier00607567700307
UDI-Public00607567700307
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K130382
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/23/2023
Device Model NumberHS-3045
Device Catalogue NumberHS-3045
Device Lot Number3000261689
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/15/2023
Supplement Date Received by Manufacturer08/24/2023
Initial Report FDA Received Date07/10/2023
Supplement Report FDA Received Date08/25/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/24/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
UNKNOWN.
Patient SexUnknown
-
-